Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble ST2 as a marker for risk of mortality in HIV-infected subjects

Soluble ST2 as a marker for risk of mortality in HIV-infected subjects

US Patent 9804172 · Granted Oct 31, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies against human CD39 and use thereof for inhibiting T regulatory cells 2023
Methods and compositions for treating and preventing HIV2022
Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides2021
Methods and compositions for treating and preventing HIV2020
Diagnostic markers of immunosenescence and methods for determining the susceptib2020
Diagnostic markers of immunosenescence and methods for determining the susceptib2020
Antibodies against human CD39 and use thereof for inhibiting T regulatory cells 2020
Methods and compositions for treating and preventing HIV2020
P2X7 receptor antagonists for restoring T-cell lymphopoiesis in subjects infecte2020
P2X7 receptor antagonists for restoring T-cell lymphopoiesis in subjects infecte2020
Compositions and methods to immunize against hepatitis C virus2018
Dendritic cell vaccines2018